Hodgkin’s Lymphoma Patient Responds Well to Off-label Therapy with Nivolumab
News
Promising results from what is believed to be the first patient treated with nivolumab after allogeneic stem cell transplantation (alloSCT) has recently been reported in a case study titled “Nivolumab in ... Read more